Gilbertson RJ. Mapping cancer origins. Cell. 2011;145:25–9. https://doi.org/10.1016/j.cell.2011.03.019.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tanaka I, Chakraborty A, Saulnier O, Benoit-Pilven C, Vacher S, Labiod D, et al. ZRANB2 and SYF2-mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin. Nucleic Acids Res. 2020;48:2676–93. https://doi.org/10.1093/nar/gkz1213.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hanley R, Pagliari F, Garcia-Calderón D, Fernandes Guerreiro J, Genard G, Jansen J, et al. Radio-resistance of hypoxic tumors: exploring the effects of oxygen and x-ray radiation on non-small lung cancer cell lines. Radiat Oncol. 2023;18:81. https://doi.org/10.1186/s13014-023-02275-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Warburg O. On the origin of cancer cells. Science. 1956;123:309–14. https://doi.org/10.1126/science.123.3191.309.

Article  CAS  PubMed  Google Scholar 

Icard P, Shulman S, Farhat D, Steyaert JM, Alifano M, Lincet H. How the Warburg Effect supports aggressiveness and drug resistance of cancer cells? Drug Resist Updat. 2018;38:1–11. https://doi.org/10.1016/j.drup.2018.03.001.

Article  PubMed  Google Scholar 

Yin F, Zhang X, Zhang Z, Zhang M, Yin Y, Yang Y, et al. ERK/PKM2 is mediated in the Warburg Effect and cell proliferation in arsenic-induced human L-02 hepatocytes. Biol Trace Elem Res. 2024;202:493–503. https://doi.org/10.1007/s12011-023-03706-z.

Article  CAS  PubMed  Google Scholar 

Liu J, Chen G, Liu Z, Liu S, Cai Z, You P, et al. Aberrant FGFR tyrosine kinase signaling enhances the Warburg Effect by reprogramming LDH isoform expression and activity in prostate cancer. Cancer Res. 2018;78:4459–70. https://doi.org/10.1158/0008-5472.Can-17-3226.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ashizawa K, Willingham MC, Liang CM, Cheng SY. In vivo regulation of monomer-tetramer conversion of pyruvate kinase subtype M2 by glucose is mediated via fructose 1,6-bisphosphate. J Biol Chem. 1991;266:16842–6.

Article  CAS  PubMed  Google Scholar 

Dong G, Mao Q, Xia W, Xu Y, Wang J, Xu L, et al. PKM2 and cancer: The function of PKM2 beyond glycolysis. Oncol Lett. 2016;11:1980–6. https://doi.org/10.3892/ol.2016.4168.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li L, Zhang Y, Qiao J, Yang JJ, Liu ZR. Pyruvate kinase M2 in blood circulation facilitates tumor growth by promoting angiogenesis. J Biol Chem. 2014;289:25812–21. https://doi.org/10.1074/jbc.M114.576934.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang W, Lu Z. Nuclear PKM2 regulates the Warburg effect. Cell Cycle. 2013;12:3154–8. https://doi.org/10.4161/cc.26182.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luo W, Hu H, Chang R, Zhong J, Knabel M, O’Meally R, et al. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell. 2011;145:732–44. https://doi.org/10.1016/j.cell.2011.03.054.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao X, Wang H, Yang JJ, Liu X, Liu ZR. Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase. Mol Cell. 2012;45:598–609. https://doi.org/10.1016/j.molcel.2012.01.001.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu P, Li AX, Chen XS, Tian M, Wang HY, Wang XL, et al. PKM2-c-Myc-Survivin cascade regulates the cell proliferation, migration, and tamoxifen resistance in breast cancer. Front Pharmacol. 2020;11:550469. https://doi.org/10.3389/fphar.2020.550469.

Chen YL, Song JJ, Chen XC, Xu W, Zhi Q, Liu YP. Mechanisms of pyruvate kinase M2 isoform inhibits cell motility in hepatocellular carcinoma cells. World J Gastroenterol. 2015;21:9093–102. https://doi.org/10.3748/wjg.v21.i30.9093.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang W, Xia Y, Ji H, Zheng Y, Liang J, Huang W, et al. Corrigendum: Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation. Nature. 2017;550:142. https://doi.org/10.1038/nature24008.

Article  CAS  PubMed  Google Scholar 

Sarfraz I, Rasul A, Jabeen F, Sultana T, Adem Ş. Identification of natural compounds as inhibitors of Pyruvate Kinase M2 for cancer treatment. Molecules. 2022. https://doi.org/10.3390/molecules27207113.

Article  PubMed  PubMed Central  Google Scholar 

Wang H, Wang X, Xu L, Lin Y, Zhang J, Cao H. Identification of genomic alterations and associated transcriptomic profiling reveal the prognostic significance of MMP14 and PKM2 in patients with pancreatic cancer. Aging (Albany NY). 2020;12:18676–92. https://doi.org/10.18632/aging.103958.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu J, Zhi Q, Liu Y, Wang Y, Chen L, Ke Y, et al. Insulin promotes hepatocarcinoma tumorigenesis by up-regulating PKM2 expression. Exp Cell Res. 2021;408:112872. https://doi.org/10.1016/j.yexcr.2021.112872.

Article  CAS  PubMed  Google Scholar 

Israelsen WJ, Dayton TL, Davidson SM, Fiske BP, Hosios AM, Bellinger G, et al. PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells. Cell. 2013;155:397–409. https://doi.org/10.1016/j.cell.2013.09.025.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang D, He Z, Shen Y, Wang J, Liu T, Jiang J. MiR-489-3p reduced pancreatic cancer proliferation and metastasis by targeting PKM2 and LDHA involving glycolysis. Front Oncol. 2021;11:651535. https://doi.org/10.3389/fonc.2021.651535.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cui K, Wu H, Fan J, Zhang L, Li H, Guo H, et al. The mixture of Ferulic Acid and P-Coumaric Acid suppresses colorectal cancer through lncRNA 495810/PKM2 mediated aerobic glycolysis. Int J Mol Sci. 2022. https://doi.org/10.3390/ijms232012106.

Anastasiou D, Yu Y, Israelsen WJ, Jiang JK, Boxer MB, Hong BS, et al. Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis. Nat Chem Biol. 2012;8:839–47. https://doi.org/10.1038/nchembio.1060.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fu R, Yang P, Amin S, Li Z. A novel miR-206/hnRNPA1/PKM2 axis reshapes the Warburg effect to suppress colon cancer growth. Biochem Biophys Res Commun. 2020;531:465–71. https://doi.org/10.1016/j.bbrc.2020.08.019.

Article  CAS  PubMed  Google Scholar 

Muirhead H, Clayden DA, Barford D, Lorimer CG, Fothergill-Gilmore LA, Schiltz E, et al. The structure of cat muscle pyruvate kinase. EMBO J. 1986;5:475–81. https://doi.org/10.1002/j.1460-2075.1986.tb04236.x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Noguchi T, Inoue H, Tanaka T. The M1- and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing. J Biol Chem. 1986;261:13807–12.

Article  CAS  PubMed  Google Scholar 

Takenaka M, Noguchi T, Inoue H, Yamada K, Matsuda T, Tanaka T. Rat pyruvate kinase M gene. Its complete structure and characterization of the 5’-flanking region. J Biol Chem. 1989;264:2363–7.

Article  CAS  PubMed  Google Scholar 

Buneeva O, Kopylov A, Gnedenko O, Medvedeva M, Veselovsky A, Ivanov A, et al. Proteomic profiling of mouse brain pyruvate kinase binding proteins: a hint for moonlighting functions of PKM1? Int J Mol Sci. 2023. https://doi.org/10.3390/ijms24087634.